Malawi
Tuberculosis profile
| High HIV burden |
Population  2012 16 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 1.4 (0.57–2.7) 9 (3.6–17)
Mortality (HIV+TB only) 3.5 (3.1–4.3) 22 (20–27)
Prevalence  (includes HIV+TB) 22 (11–36) 140 (72–229)
Incidence  (includes HIV+TB) 26 (24–28) 163 (151–176)
Incidence (HIV+TB only) 16 (15–17) 100 (93–108)
Case detection, all forms (%) 78 (73–85)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 6 951 (38) Relapse 694 (84)
Smear-negative 6 550 (36) Treatment after failure 85 (10)
Smear-unknown / not done 0 (0) Treatment after default 43 (5)
Extrapulmonary 4 886 (27) Other    
Other 0 (0)      
Total new 18 387   Total retreatment 822  
           
Other (history unknown) 1 254        
Total new and relapse 19 081   Total cases notified 20 463  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 1.4    
Age < 15 123    
Laboratories 2012
Smear (per 100 000 population) 1.4
Culture (per 5 million population) 1.3
Drug susceptibility testing (per 5 million population) 0.6
Is second-line drug susceptibility testing available? No
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 85   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 82  
Retreatment 82  
TB/HIV 2012 Number (%)
TB patients with known HIV status 19 009 (93)
HIV-positive TB patients 11 296 (59)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 9 928 (88)
HIV-positive TB patients on antiretroviral therapy (ART) 9 144 (81)
HIV-positive people screened for TB 393 031  
HIV-positive people provided with IPT 20 542  
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 0.42 (0.14–0.97) 4.8 (3.2–6.9)
MDR-TB cases among notified pulmonary
TB cases
56 (18–130) 40 (27–57)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 0 (0%) 27 (3%) 27
Laboratory-confirmed MDR-TB cases 0 27 27
Patients started on MDR-TB treatment     26
Financing TB control 2013
National TB programme budget (US$ millions) 6.6
% Funded domestically 51%
% Funded internationally 45%
% Unfunded 4%
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-23 Data: www.who.int/tb/data